|
|
| | L-Leucine, L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-L-valylglycyl- Basic information |
| | L-Leucine, L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-L-valylglycyl- Chemical Properties |
| Boiling point | 1402.1±65.0 °C(Predicted) | | density | 1.250±0.06 g/cm3(Predicted) | | pka | 3.40±0.10(Predicted) |
| | L-Leucine, L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-L-valylglycyl- Usage And Synthesis |
| Uses | HBV Seq2 aa:179-186 serve as effective motifs for CTL response in H-2b system after in vitro restimulation of the primed T cells. HBV Seq2 aa:179-186 is a novel epitope identified on the surface antigen of hepatitis B virus[1]. | | References | [1] Roh S, et, al. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses. Virus Res. 2001 Jan;73(1):17-26. DOI:10.1016/s0168-1702(00)00219-7 |
| | L-Leucine, L-phenylalanyl-L-valyl-L-glutaminyl-L-tryptophyl-L-phenylalanyl-L-valylglycyl- Preparation Products And Raw materials |
|